Author: Ravi Shankar

NEW ALBANY, Ohio, Oct. 20, 2026 (GLOBE NEWSWIRE) — Commercial Vehicle Group (the “Company” or “CVG”) (NASDAQ: CVGI) will hold its quarterly conference call on Tuesday, November 3, 2026, at 8:30 a.m. ET, to discuss third quarter 2026 financial results. CVG will issue a press release and presentation prior to the conference call.
        
Toll-free participants dial (833) 461-5787 using conference code 391633180. International participants dial (585) 542-9983 using conference code 391633180. This call is being webcast and can be accessed through the “Investors” section of CVG’s website at ir.cvgrp.com where it will be archived for one year.

About CVG

Commercial Vehicle Group, Inc. and its subsidiaries, is a global provider of systems, assemblies and components to global commercial vehicle markets and electric vehicle markets. We deliver real solutions to complex design, engineering and manufacturing problems while creating positive change for our customers, industries, and communities we serve. Information about the Company and its products is available on the internet at www.cvgrp.com.

Investor Relations Contact:
Ross Collins or Nathan Skown
Alpha IR Group
CVGI@alpha-ir.com                                                                                                                                                                                                                                                                                                                                                                    

Saran Saund to connect the emerging research approach with PDAOAI intellectual property, plans for 100 billion biological vectors, individual researcher access through Fastbot/Membot and an HCC case study

AGOURA HILLS, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”) today announced that Chief Business Officer Saran Saund will deliver the opening keynote on Day 2 of the 22nd Drug Discovery Strategic Summit on October 22, 2026. The presentation will examine partition and aggregation as a fundamental organizing principle for AI-enabled discovery: dividing complex research questions into focused investigations, examining them in parallel and combining the evidence to identify hypotheses worth testing.

Anthropic recently reported that Claude searched biological sequence data in 949 agent sessions over 21.5 hours and identified an enzyme system with CRISPR-like repeats, termed array-associated reverse transcriptases. Oncotelic views this workflow as an example of the broader value of partitioned investigation and evidence aggregation.

The keynote will show how researchers can divide complex questions into focused investigations and combine the findings into testable hypotheses—using PDAOAI or another platform. Saund will connect this broader shift with the Company’s proprietary technology and international intellectual-property strategy, its planned expansion into genetic discovery, and Fastbot/Membot, which opens the PDAOAI platform to individual researchers investigating their own questions.

“Every research organization needs to consider how it divides its questions, investigates the parts and brings the evidence back together,” said Saund. “Partition and aggregation provide a framework for that work. Its significance extends beyond any one technology provider. At PDAOAI, we are putting it into practice at the scale of both large discovery campaigns and the individual researcher.”

Keynote details

22nd Drug Discovery Strategic Summit, organized by Agile Falcon Strategic Group
Thursday, October 22, 2026, 9:00–9:25 a.m. Pacific Time
The Westin San Francisco Airport, Millbrae, California
Event information: https://agilefalconsg.com/ddss-wc/

PDAOAI technology and intellectual property

PDAOAI is an AI-powered drug discovery platform developed by Oncotelic Therapeutics, Inc. Its current platform index covers approximately 29 million PubMed abstracts. It applies Partitioned Literature Aggregation to research questions in target discovery, drug repurposing and therapeutic development, with evidence traceable to source publications. Fastbot/Membot provides an access point for individual researchers. For more information, visit www.pdaoai.com. Oncotelic has filed patent applications internationally and received a patent grant in Mexico. Applications in other jurisdictions continue through examination.

BIO REBOOT

Through BIO REBOOT, individuals and teams can bring research questions, technical expertise and drug discovery ideas to the PDAOAI community. Registration is free at https://pdaoai.com/bio-reboot.

Selected projects may be considered for startup funding and Oncotelic support spanning validation, formulation, regulatory planning and clinical development. Funding, platform access and development support are subject to scientific review, available resources and agreed terms.

About Oncotelic

Oncotelic Therapeutics, Inc. develops oncology and immunotherapy products, with a focus on cancers with substantial unmet needs and rare pediatric indications. Alongside its own drug development programs, the Company licenses and co-develops selected candidates through partnerships and joint ventures, including its 45% interest in GMP Bio. Oncotelic also develops the PDAOAI platform to support its work in drug discovery and development. Additional information is available at www.oncotelic.com.

Oncotelic Cautionary Note on Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this communication regarding strategy, future operations, future financial position, prospects, plans and objectives of management are forward-looking statements. Words such as “may,” “expect,” “anticipate,” “plan,” “intend,” “believe,” “estimate,” “target” and “will” can identify forward-looking statements. Forward-looking statements in this release include the Company’s anticipated conference participation; the development, availability, adoption and potential utility of PDAOAI, PLA and Fastbot; the potential value, scope and future development of its intellectual-property portfolio; plans to extend the platform to genetic and protein discovery at a target scale of approximately 100 billion vectors; the potential significance and further validation of the HCC findings; and BIO REBOOT collaborations, potential startup funding, platform access and development support. Each of these forward-looking statements involves risks and uncertainties, and actual results may differ materially from these forward-looking statements or may not occur at all. Many factors may cause differences between current expectations and actual results, including unexpected safety or efficacy data observed during preclinical or clinical studies, clinical trial site activation or enrollment rates that are lower than expected, changes in expected or existing competition, changes in the regulatory environment, failure of collaborators to support or advance collaborations or product candidates and unexpected litigation or other disputes. These risks are not exhaustive. The Company faces known and unknown risks, including the risk factors described in the Company’s 2025 Annual Report on Form 10-K filed with the SEC on April 15, 2026 and in the Company’s other periodic filings. Forward-looking statements are based on expectations and assumptions as of the date of this press release. Except as required by law, the Company does not assume any obligation to update forward-looking statements contained herein to reflect any change in expectations, whether because of new information, future events, or otherwise.

Contact information

For Oncotelic Therapeutics, Inc.
Investor Relations
ir@oncotelic.com

A majority of the investors in the 30,000,000-share Class B offering completed September 27, 2026 have agreed to a 90-day lock-up and staged release, with early release only if TDTH closes at or above US$8.00 per share for five consecutive trading days

SINGAPORE, Oct. 20, 2026 (GLOBE NEWSWIRE) — Trident Digital Tech Holdings Ltd (“Trident” or the “Company”) (Nasdaq: TDTH) today announced that a majority of the investors in its September 27, 2026 equity offering have entered into lock-up and leak-out agreements with the Company covering the Class B ordinary shares they purchased in that offering. Under the agreements, those shares may be released early from all restrictions only if Trident’s Class B ordinary shares close at or above US$8.00 per share for five consecutive trading days.

The shares were issued under the Company’s effective shelf registration statement and carried no contractual resale restriction when sold. The investors have voluntarily agreed to hold them through a defined schedule tied to the Company’s execution of the priorities it set out on September 29, 2026.

Terms of the Lock-Up and Leak-Out Agreements

Lock-Up Period. From October 17, 2026 through January 17, 2027, no covered shares may be sold, transferred, hedged, shorted or otherwise disposed of, directly or indirectly, including through swaps or derivative positions. The restriction extends to each investor’s controlled affiliates.

Staged Release. Following the Lock-Up Period, covered shares are released in three equal tranches on February 16, March 18 and April 17, 2027.

Price-Based Acceleration. All remaining covered shares are released early only if the official Nasdaq closing price of Trident’s Class B ordinary shares equals or exceeds US$8.00 per share for five consecutive trading days after the Lock-Up Period ends.

Enforcement. Covered shares carry a restrictive legend and stop-transfer instructions at the Company’s transfer agent. The agreements provide the Company with specific performance, liquidated damages and an automatic extension of the restricted period in the event of any breach, and expressly preserve all restrictions imposed by applicable securities laws, including on trading while in possession of material non-public information.

Trident is continuing to work with the remaining investors in the September 27 offering to bring them under the same terms and will update the market as additional agreements are executed.

Capital Aligned With Execution

The agreements align the September 27 capital with the operating program Trident committed to on September 29: scaling Sikaflow and the Ghana Revenue Authority digital tax platform across Ghana’s more than two million MSMEs; funding the build-out of the IRMA Asia enterprise-AI joint venture across Asia, the Middle East and Africa; and establishing a regional cybersecurity business around Memcyco’s real-time fraud defence. Trident will report progress against each of these priorities on measurable milestones, as previously announced, and the release dates under the agreements now fall within the period in which that progress will be reported.

“The investors who funded Trident in September have now put their capital on the same timeline as our execution,” said Soon Huat Lim, Founder, Chairman and Chief Executive Officer of Trident. “They purchased freely tradable shares and chose to hold them — with the only early exit set at US$8.00 per share. That is a statement about where they believe this Company is going. Our job is to deliver the milestones in Ghana, in enterprise AI and in cybersecurity that justify it, and we intend to report on every one of them.”

The foregoing description of the lock-up and leak-out agreements is a summary only and is qualified in its entirety by the form of agreement to be furnished by the Company in a Report of Foreign Private Issuer on Form 6-K filed with the U.S. Securities and Exchange Commission (“SEC”) and available at www.sec.gov. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities.

About Trident Digital Tech Holdings Ltd

Trident Digital Tech Holdings Ltd (Nasdaq: TDTH) is a Singapore-headquartered digital infrastructure holding company that builds and operates AI and digital platforms for enterprises, small and medium-sized businesses, and governments in emerging markets across Asia-Pacific, the Middle East and Africa. Through TDTHAI and its IRMA Engine Asia joint venture, Trident is commercializing enterprise AI across three continents. In Ghana, through Trident Aliska Digital Tech Ghana Ltd., the Company operates the Sikaflow MSME digital financial infrastructure platform and supports the Ghana Revenue Authority digital tax platform launched June 24, 2026. For more information, visit https://tridentity.me.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s intention to enter into additional lock-up and leak-out agreements, the Company’s operating priorities, milestones and timing, and the anticipated effect of the agreements on the trading of the Company’s securities. Words such as “will,” “intends,” “plans,” “expects,” “aims,” “may” and similar expressions identify forward-looking statements. These statements are based on management’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including: the Company’s ability to execute additional agreements with the remaining investors; the possibility that covered shares are released early upon satisfaction of the price-based acceleration condition or are sold following their scheduled release; the Company’s ability to enforce the agreements; volatility in the market price of the Company’s shares; the Company’s ability to deploy proceeds effectively and achieve stated milestones on anticipated timelines; the Company’s ability to maintain compliance with Nasdaq continued listing requirements; and the other risks described in the Company’s filings with the SEC, including its most recent Annual Report on Form 20-F. Nothing in this press release should be read as a prediction of, or target for, the future trading price of the Company’s securities. Forward-looking statements speak only as of the date of this release, and the Company undertakes no obligation to update them except as required by law.

CONTACT: Public Relations & Global Partnerships:
Phoenix MGMT & Consulting
www.PhoenixMGMTconsulting.com
PR@PhoenixMGMTConsulting.com

Partnership built over the past two seasons moves into a new chapter at the Bills’ new home in Orchard Park

NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) — With the NFL season in full swing and more than 60,000 fans packing the new Highmark Stadium on game day, ABM (NYSE: ABM), a leading provider of facility, engineering, and infrastructure solutions, is building on its two-year partnership with the Buffalo Bills, providing janitorial services and light operational support at the team’s new home in Orchard Park. After supporting the Bills at their former stadium since the 2024 season, ABM has made the move across the street with the team, helping keep Highmark Stadium ready for fans throughout the season and beyond.

Now in its first season, the 60,108-seat Highmark Stadium is welcoming Bills fans into a new era, and ABM is helping make sure it’s ready for them. From before the gates open until long after the final whistle, ABM’s on-site support helps prepare the stadium for the demands that come with welcoming tens of thousands of fans through its gates.

“There’s nothing quite like the energy of a packed stadium, but delivering that experience starts long before fans come through the gates,” said Valerie Burd, President, Business & Industry, ABM. “Highmark Stadium marks an exciting new chapter for the Bills, their fans, and our partnership. We’re proud to be part of this moment and look forward to continuing to grow alongside the Bills in the years ahead.”

Supporting the Bills through this transition builds on ABM’s track record of opening major sports and entertainment venues including SoFi Stadium, Allegiant Stadium, and Levi’s Stadium. Drawing on that proven playbook, ABM provided guidance as Highmark Stadium took shape and developed an operating approach tailored to the demands of a modern, high-traffic venue.

“Game day at a venue like Highmark Stadium takes an incredible amount of preparation and coordination behind the scenes,” said Brian Grant, Vice President, Sports & Entertainment, ABM. “Our first two seasons with the Bills gave us the opportunity to build our local team, learn their operation, and prepare together for the move to Highmark Stadium. Now, our focus is on delivering consistently for the Bills and their fans every week while staying ready for whatever comes next.”

“Opening Highmark Stadium represents an incredible moment for the Buffalo Bills and our fans, and having trusted partners alongside us is an important part of delivering the experience we want for everyone who comes through our doors,” said Andy Major, SVP of Venue Operations & Fan Experience, Buffalo Bills. “ABM has taken the time to understand our operation and our expectations, and we look forward to continuing our work together at Highmark Stadium.”

Highmark Stadium joins a growing portfolio of iconic sports and entertainment destinations supported by ABM across the country. From everyday facility operations to the demands of game days and major events, ABM helps venues create clean, welcoming, and ready environments for the fans, teams, and communities they serve.

For more information about ABM’s Sports & Entertainment solutions, visit www.abm.com/industries/sports-entertainment.

About ABM
ABM (NYSE: ABM) is one of the world’s largest providers of integrated facility, engineering, and infrastructure solutions. Every day, our over 100,000 team members deliver essential services that make spaces cleaner, safer, and efficient, enhancing the overall occupant experience.

ABM serves a wide range of market sectors including commercial real estate, aviation, education, mission critical, and manufacturing and distribution. With over $8 billion in annual revenue and a blue-chip client base, ABM delivers innovative technologies and sustainable solutions that enhance facilities and empower clients to achieve their goals. Committed to creating smarter, more connected spaces, ABM is investing in the future to meet evolving challenges and build a healthier, thriving world. ABM: Driving possibility, together.

For more information, visit www.ABM.com.

MEDIA CONTACT:
Michael Valentino
ABM
media@abm.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e837ef92-3fdb-4d6e-a997-67d3c7b691e0

Agreement with global fintech serving more than 80 million customers expands distribution opportunities for Rezolve’s merchant network

NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a global leader in AI-powered commerce and payments solutions, today announced a commercial agreement with Revolut through its Reward business, opening a new channel for participating retail partners to reach eligible customers within one of the world’s leading financial apps.

The agreement strengthens Rezolve Ai’s ability to connect merchants with consumers where they already manage and spend their money. It creates a foundation for expanding merchant participation and transaction-linked rewards across agreed markets, supporting Rezolve Ai’s strategy of driving organic growth through broader distribution.

For Rezolve Ai, the significance extends beyond individual campaigns. The relationship broadens the distribution opportunity for its Reward business and advances its strategy of embedding customer engagement and loyalty into the financial platforms consumers use every day.

Daniel M. Wagner, Founder, Chairman and CEO of Rezolve Ai, commented:
“Revolut has helped redefine financial services. This agreement gives Rezolve Ai a powerful new channel to connect our merchant partners with consumers and turn customer engagement into purchases.

“Our ambition is to make Rezolve Ai central to how people discover, buy and return to the brands they love. That requires both technology and distribution. Our capabilities underpin that broader vision, while this agreement expands the commercial reach of our Reward business.

“For shareholders, the opportunity is clear: broaden our distribution, attract more participating merchants and grow the business through transactions that deliver value to retailers and consumers alike.”

Expanding Rezolve Ai’s commercial reach
Rezolve Ai’s strategy brings together product discovery, customer engagement, payments and loyalty, helping retailers connect more effectively with consumers throughout the purchasing journey.

Within that strategy, Rezolve Reward provides an established connection between retail brands and financial services platforms. The Revolut agreement adds a new distribution channel, creating opportunities to expand merchant participation and develop campaigns across agreed markets.

The commercial model connects merchant-funded rewards with qualifying purchases, aligning retailer investment with customer activity. Individual campaigns, including participating merchants, markets, incentive rates and launch dates, will be agreed separately.

Sophie Tran, Head of Global Affiliate Partnership, Revolut, will be speaking to James House, CEO of Rezolve Reward, today at Money2020 in Las Vegas in a session at 2.20pm: Beyond Payments: Retail Growth without Borders at Rezolve Stand 11041 and 11047.

About Rezolve Ai
Rezolve Ai is a global leader in AI-powered commerce and engagement. Its technology helps retailers, brands, financial institutions and commerce platforms create intelligent, personalized customer experiences across search, discovery, engagement and transaction journeys.

Rezolve Ai’s platform is designed to connect consumers, merchants, banks and payment providers through intelligent commerce infrastructure that makes customer interactions more relevant, measurable and valuable. Through its AI-powered commerce capabilities and Reward’s financial engagement platform, Rezolve Ai is building the infrastructure for the next generation of personalized and agentic commerce.

Media Contact
Urmee Khan
Global Director of Communications & Corporate Affairs
urmeekhan@rezolve.com
+44 7576 094 040

Forward-Looking Statements
This announcement contains forward-looking statements regarding the expected benefits of the Revolut agreement, expansion opportunities and future growth. Actual results may differ materially due to factors including campaign implementation, merchant participation, customer adoption, market conditions and the risks described in Rezolve AI’s filings with the U.S. Securities and Exchange Commission. Campaign availability and scope remain subject to separately agreed terms. Rezolve AI undertakes no obligation to update these statements except as required by law.

SYDNEY, Oct. 20, 2026 (GLOBE NEWSWIRE) — Brazilian Rare Earths Limited (ASX: BRE / OTCQX: BRELY) (‘BRE’) is pleased to report progress during the quarter ended September 30, 2026. Highlights during and subsequent to the end of the quarter include:

MAIDEN ULTRA-HIGH GRADE MINERAL RESOURCE

• World-leading rare earths grade: Monte Alto’s Mineral Resource grades 11.3% TREO, more than twice the reported grades of the two established large-scale Western rare earth producers.
• Major new source of heavy rare earths plus strategic co-products: Strong dysprosium, terbium, gadolinium and yttrium enrichment, alongside potential uranium, scandium, niobium and tantalum co-products.

INTEGRATED MONTE ALTO + CAMAÇARI SCOPING STUDY

• Exceptional economics: After-tax NPV₈ of US$6.0 billion, IRR of 90%, 1.1-year payback and average annual operating free cash flow of US$1.2 billion.¹
• First-quartile project: Ultra-high grades, simple ore sorting, high yields, established infrastructure and low-temperature processing underpin costs of ~US$21/kg NdPr equivalent.

SUCCESSFUL DRILLING POSITIONS MONTE ALTO FOR RESOURCE GROWTH

• Ultra-high grade extensions: ~10,000 m of drilling completed after the 22 February 2026 Scoping Study cut-off expanded mineralisation south and east/down dip and established a priority growth corridor to the north.
• Q4 2026 resource upgrade: Post-cut-off results could, subject to conversion into Mineral Resources and further studies, support mine life extension and/or increased annual production.

HIGH-GRADE SULISTA SOUTH DISCOVERY AND EXTENSIONS AT SULISTA EAST

• New discovery and extensions: High-grade mineralisation intersected over ~500 m of strike at Sulista South, while step-out drilling extended Sulista East by 430 m.
• Larger, higher-confidence resource targeted: Current step-out and infill drilling campaigns support potential resource growth and Inferred-to-Indicated conversion; updated mineral resource to follow their completion.

PRODUCED FIRST CONCENTRATE; SECURED STAGE II HYDROMET CO-FUNDING

• First concentrate: Stage I commissioning at Camaçari advances bulk metallurgical testwork for the PFS.
• Hydromet piloting: Stage II is 59% partner-funded, with commissioning planned for Q2 2027.

STRONG BALANCE SHEET TO FUND GROWTH

• A$122 million cash and no borrowings at 30 September 2026.

A link to the complete announcement can be found: here

Contacts

Bernardo Da Veiga
Managing Director and CEO

investors@brazilianrareearths.com
www.brazilianrareearths.com

__________________________________
_{¹ Argus EU/US price case. Refer to the Scoping Study cautionary statement in this report and BRE’s ASX announcement dated 18 August 2026.}

Former CoBank CEO and Former CFO of Annie’s, KIND and BARK Join as Independent Directors

OCEANSIDE, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) — Suja Life, Inc. (NASDAQ: SUJA) (“Suja Life,” “Suja” or the “Company”), a leading better-for-you beverage company and maker of Suja Organic, Vive Organic and Slice Soda, today announced the appointments of Robert B. Engel and Zahir Ibrahim as independent members of its Board of Directors (the “Board”), effective October 16, 2026. Engel will serve on the Board’s Audit Committee. With these appointments, Suja Life’s Board comprises nine directors, seven of whom are independent.

The appointments add deep financial, accounting and capital markets expertise to the Board as Suja Life continues to build its portfolio of better-for-you beverage brands. Engel, the former President and CEO of CoBank, brings more than 45 years of experience across banking, public accounting and public company board leadership. Ibrahim brings nearly 30 years of financial leadership at public and private consumer companies, including as Chief Financial Officer of Annie’s, KIND and BARK.

“We are pleased to welcome Bob Engel and Zahir Ibrahim to Suja Life’s Board of Directors,” said Bob DeBorde, Chairman of Suja Life. “Bob Engel brings extensive financial and risk oversight experience as well as deep knowledge of food and agribusiness as a former bank CEO, CPA and public company director. Zahir has served as CFO of leading natural and healthy consumer brands, including Annie’s and KIND, through periods of significant growth. Their perspectives will strengthen our Board as we execute our growth strategy and create long-term value for our shareholders.”

About Robert B. Engel

Engel spent 17 years at CoBank, ACB, first as President and Chief Operating Officer and then as President and Chief Executive Officer, leading the bank’s domestic and global businesses and its merger with U.S. AgBank. Before CoBank, he spent 14 years at HSBC Bank USA in roles of increasing responsibility, ultimately serving as Chief Banking Officer. He began his career in public accounting at Deloitte & Touche and KPMG, rising to Senior Audit Manager, and is a Certified Public Accountant.

Since 2017, Engel has served as Chief Executive Officer and Managing Director of BLT Advisory Services, LLC, an advisory firm he founded that guides companies on business transformation, mergers and acquisitions, governance and leadership development. He is also an independent director of Allient, Inc. (NASDAQ: ALNT), where he serves on the Audit Committee, and Chairman of the Board of Alaska Power & Telephone. He previously served as an independent director of Heartland Financial USA, Inc., then listed on NASDAQ, where he chaired the Risk Committee. Engel is a recipient of the Ellis Island Medal of Honor.

About Zahir Ibrahim

Ibrahim most recently served as Chief Financial Officer of BARK, Inc. (NYSE: BARK). Before BARK, he was Chief Financial Officer and Chief Administrative Officer of Do Good Foods. He previously served as Chief Financial Officer of KIND, where he helped build the infrastructure behind the healthy snack brand’s growth and international expansion and led the company through its sale to Mars in 2020. Before KIND, he was Chief Financial Officer of Annie’s, Inc., then listed on the NYSE, where he led the natural and organic food company through a period of significant growth and its sale to General Mills. Earlier, Ibrahim held several roles at Molson Coors Brewing Company, culminating as Vice President, Controller and Chief Accounting Officer. He trained as a Chartered Accountant with KPMG.

About Suja Life

At Suja Life, we’re changing what beverages bring to the table. We make organic, cold-pressed juices, wellness shots, and better-for-you sodas that deliver real functional benefits, exceptional taste, and high-quality ingredients, because we believe beverages should be as delicious as they are good for you. Our three brands – Suja Organic, Vive Organic, and Slice Soda – reach consumers through thousands of retail doors nationally. We operate a vertically integrated high-pressure processing and cold-pressed beverage facility, processing approximately 1 million pounds of organic produce each week and moving from farm to bottle in as few as eight days. With category-leading brands, a dedication to operational excellence, and a proven innovation engine, Suja Life is positioned at the front of the growing natural healthy beverage space.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact included in this press release are forward-looking statements. These statements may include words such as “anticipate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “will,” “should,” “can have,” “likely,” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future performance or other events. For example, statements regarding Mr. Engel’s and Mr. Ibrahim’s expected contributions to the Company are forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected, including: the ability of our newly appointed directors to contribute to the Board and its committees as anticipated; our ability to execute our growth strategy; and the other factors set forth in our filings with the U.S. Securities and Exchange Commission.

The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Investor and Press Contact

Michael Mougias
Investors@Sujalife.com
Press@Sujalife.com

BOSTON, Oct. 20, 2026 (GLOBE NEWSWIRE) — Today, Flywire Corporation (Flywire) (Nasdaq: FLYW), a global payments enablement and software company, announced that its third quarter financial results will be released after market close on Tuesday, November 3, 2026. Flywire will host a conference call to discuss its third-quarter financial results at 5:00 pm ET the same day. Hosting the call will be Mike Massaro, CEO, Rob Orgel, President and COO, and Cosmin Pitigoi, CFO.

The conference call will be webcast live from Flywire’s investor relations website at https://ir.flywire.com/. A replay will be available on the investor relations website following the call.

About Flywire
Flywire is a global payments enablement and software company. We combine our proprietary global payments network, next-generation payments platform, and vertical-specific software to deliver the most complex and critical payments for our clients and their customers.

Flywire leverages its vertical-specific software and payments technology to deeply embed within the existing A/R workflows for its clients across the education, healthcare, and travel vertical markets, as well as in key B2B industries. Flywire also integrates with leading ERP systems, such as NetSuite, so organizations can optimize the payment experience for their customers while eliminating operational challenges.

Flywire supports over 5,300** clients with diverse payment methods in more than 140 currencies across over 240 countries and territories worldwide. The company is headquartered in Boston, MA, USA, with global offices. For more information, visit www.flywire.com. Follow Flywire on X, LinkedIn, and Facebook.

Contacts
Investor Relations:
Masha Kahn
ir@Flywire.com 

Media:
Sarah King
media@flywire.com

**Excludes clients from Flywire’s Invoiced and Sertifi acquisitions

• Rocket Doctor selected as a Best in Class Finalist in the “Civic Health: Affordability, Access & Health Equity” category out of 1,800 global applicants.

• Company featured in the “Innovations from Canada” Pavilion and pitch competition at HLTH in Las Vegas on November 16, 2026.
  

VANCOUVER, British Columbia, Oct. 20, 2026 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc.  (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”) is pleased to announce that its wholly owned subsidiary, Rocket Doctor Inc., has been selected as a Finalist in the 8th Annual Digital Health & AI Awards, hosted by the Digital Health Hub Foundation at HLTH 2026 in Las Vegas.

Rocket Doctor was selected as one of only five finalists in the “Best in Class” Track for Civic Health: Affordability, Access & Health Equity, chosen from a competitive field of over 1,800 submissions worldwide. The recognition honors companies delivering remarkable innovation, measurable clinical impact, and transformation across the digital health and AI ecosystem.

In addition to being named an award finalist, Rocket Doctor will participate in the “Innovations from Canada” Global Village on Monday November 16th at HLTH, presenting a pitch in the showcase, and will be prominently featured in the “Innovations from Canada” Pavilion, highlighting top Canadian digital health companies supported by the MaRS and D3 Accelerators.

“Being recognized as a finalist from among 1,800 global digital health innovators is a huge honor, and a strong validation of our mission,” said Dr. William Cherniak, Founder & CEO of Rocket Doctor Inc. “Our AI-driven platform and physician marketplace were built specifically to address critical healthcare gaps, making high-quality care accessible, affordable, and equitable for remote, rural, and underserved populations across North America, particularly for individuals on Medicaid and Medicare across the United States. We look forward to sharing our vision and presenting on stage at HLTH in Las Vegas.”

The 8th Annual Digital Health & AI Awards Grand Finale will take place on November 16th, 2026, at HLTH in Las Vegas, bringing together leaders, investors, health systems, and innovators from across the global healthcare ecosystem.

About Rocket Doctor AI Inc.

Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.

Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 350 MDs to provide care to more than 800,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices – improving efficiency, restoring autonomy to MDs, and expanding patient access to care.

By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare – making it more scalable, equitable, and patient-centered.

To learn more about Rocket Doctor AI Inc’s products and services, contact: www.rocketdoctor.ai or email: info@rocketdoctor.ai

FOR ADDITIONAL INFORMATION, CONTACT:

Dr. Essam Hamza, CEO, Rocket Doctor AI essam.hamza@rocketdoctor.ai

Dr. Bill Cherniak, CEO, Rocket Doctor Inc.bill@rocketdoctor.io For media inquiries, contact: media@rocketdoctor.ai Call: +1 (778) 819 8321

Cautionary Statements

This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects[1] ” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the Company’s participation in the 2026 Digital Health & AI Awards at HLTH, the anticipated pitch in the “Innovations from Canada” Global Village, showcasing in the “Innovations from Canada” Pavilion, and future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.’s expectations include the Company’s inability to participate in the “Innovations from Canada” Global Village or Pavilion as anticipated, changes to or cancellation of the Annual Digital Health & AI Awards, the Company’s inability to realize the anticipated business, reputational or financial benefits of its finalist recognition, and other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

SINGAPORE, Oct. 20, 2026 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group”, “GNS” or the “Company”), a leading AI-powered education group, today reported unaudited financial results of its operations for the third quarter ended September 30, 2026.

The Company reported third quarter operational revenue of $4.1 million, an 81% increase from $2.3 million in Q3 2025. Revenue also grew 39% quarter-on-quarter compared to $2.9 million in Q2 2026, driven by growth across the Company’s three business units: Genius School, Genius Academy and Genius Resorts.

Quarterly gross profit grew 108% to $2.7 million, up from $1.3 million in the prior year period. Quarterly net profit from operations reversed from $1.2 million net loss from operations in Q3 2025 to $235,000 net profit from operations in Q3 2026.

This marked the third consecutive quarter of net profit from operations, with a cumulative nine month revenue of $10.3 million and cumulative nine month net profit from operations of $6.7 million.

Third Quarter 2026 Operational Financial Highlights

• Revenue: Operational revenue of $4.1 million in Q3 2026, up 81% from $2.3 million in Q3 2025, and up 39% sequentially from $2.9 million in Q2 2026, driven by growth across all three business units.
• Gross Profit: Gross profit of $2.7 million, a 108% increase from $1.3 million in Q3 2025. Gross margin expanded to 66.1% from 57.3%, reflecting the continued shift to higher-margin education programmes. Sequentially, gross profit grew 84% from $1.5 million in Q2 2026, with gross margin expanding by 15.9 percentage points from 50.2%.
• Net Profit from Operations: The three operating business units collectively achieved $390,000 in operating profit, with all three units profitable in the quarter. Legacy costs from discontinued operations were $155,000, resulting in net profit from operations of $235,000 in Q3 2026, a reversal from a net loss from operations of $1.2 million in Q3 2025.
• EBITDA: EBITDA of $261,000 in Q3 2026, compared to negative EBITDA of $742,000 in Q3 2025.
• Cumulative Nine-Month Revenue: Cumulative revenue for the nine months ended September 30, 2026 was $10.3 million, up 112% from $4.9 million in the comparable prior year period.
• Cumulative Nine-Month Gross Profit: Gross profit for the nine months was $6.2 million, up 147% from $2.5 million in the comparable prior year period, with gross margin improving to 60.3% from 51.9%.
• Cumulative Nine-Month Net Profit from Operations: Net profit from operations for the nine months was $6.7 million, an $8.9 million reversal from a net loss from operations of $2.3 million in the comparable prior year period.

Roger James Hamilton, Founder and CEO of Genius Group, commented “The third quarter brought significant progress on the Company’s strategic and financial fronts. We have built and proven a profitable Genius City model, designed to be an integrated AI Powered lifelong learning campus with profitable revenues from Genius School for children and young adults, profitable revenue from Genius Academy for reskilling adults and profitable revenue from Genius Resorts providing F&B, entertainment and accommodation.”

“Now that we have built a profitable $10 million scalable model over the last nine months, we are now commencing our plans to scale our Genius City model globally towards our target of 100 Genius Cities. There is a growing need for data centers to deliver education and reskilling training and benefits to their local communities. Our Genius City model delivers this, empowering the communities that power AI.

Our financial wins in the last quarter are underpinned by our legal wins. On August 31, the Second Circuit Court of Appeals vacated the injunction that had restrained the Company from issuing shares, raising capital and purchasing Bitcoin. On September 27, the Federal Court denied all motions to dismiss our RICO lawsuit. We are now free to pursue the $1.2 billion capital plan we announced in August to fund our dual AI and Bitcoin treasury strategy, and we have relaunched our Bitcoin treasury in early October. We look forward to continuing our growth, as the community solution for the AI revolution.

Quarterly Reporting as a foreign private issuer

Genius Group is not required to file quarterly financial reports with the U.S. Securities and Exchange Commission. However, as part of the Company’s commitment to transparency and enhanced shareholder communication, the Company is voluntarily providing unaudited third quarter operational results. These results reflect the performance of the Company’s three operating business units – Genius School, Genius Academy and Genius Resorts – and do not include central treasury gains or losses, or central income or costs related to financing, investing, legal proceedings or central management fees. Audited financial results for the full fiscal year 2025 are available in the Company’s Annual Report on Form 20-F.

Q3 2026 Business Highlights

• Launch of Genius OS AI-Powered Product Suite: In July, the Company launched Genius OS, its full AI-agent product suite spanning Genius School, Genius Academy, Genius Resorts and Genius City, connecting to over 300 AI models and offered on free, $9 per month and $90 per month subscription tiers.
• Five-Star Hotel Certification: In July, Vision Villa Resort in Bali was awarded a Five-Star Hotel rating under Indonesia’s Star Hotel Tourism Business Certification Scheme, strengthening the Company’s hospitality brand.
• Share Loyalty Bonus Program (Second Round): The Company launched the second round of its Share Loyalty Bonus Program with a record date of July 31, 2026, offering $0.10 per qualifying share for shareholders who maintain their shares in book entry through January 30, 2027.
• Launch of $14 Million Genius City Project: In August, the Company launched the first phase of its $14 million Genius City joint venture at Nuanu Creative City, Bali, comprising Genius Zone, Genius Cafe, Genius Missions and Genius School.
• Balance Sheet Restructuring: In August, the Company announced the completion of its balance sheet restructuring, with book value increasing 57% year-on-year to $106.6 million and net asset value per share of $0.61.
• $1.2 Billion Capital Plan: On August 27, the Company announced a five-year capital plan under its $1.2 billion shelf registration, targeting $800 million in AI treasury assets, $827 million in Bitcoin treasury assets, and $2 billion in total assets by the financial year ending 2031.
• Vacatur of Preliminary Injunction: On August 31, the U.S. Court of Appeals for the Second Circuit vacated the preliminary injunction that had restrained the Company from issuing shares, raising capital and purchasing Bitcoin since March 2025. The matter has been remanded to the district court.
• RICO Lawsuit Motions to Dismiss Denied: On September 27, the Federal Court ruled in favor of Genius Group, denying all motions to dismiss in the Company’s RICO lawsuit against third parties.
• School Enrolment Growth: The Company opened the 2026/27 school year at its Nuanu campus with 235 students, approximately 65% year-on-year enrolment growth, with capacity across its Bali campuses expanded to approximately 1,000 students.
• Genius Future Summit: The Company announced the Genius Future Summit to be held November 5–6, 2026, featuring futurists Dr. Michio Kaku, Peter Diamandis and a lineup of world class entrepreneurs and thought leaders.

Recent Developments (Post Quarter-End)

• CEO Share Purchase: On October 1, CEO Roger Hamilton purchased 1,000,000 Company shares on the open market, expressing confidence in the Company’s outlook.
• Bitcoin Treasury Recommenced: On October 6, the Company announced the recommencement of Bitcoin treasury purchases.
• Launch of Genius High: On October 13, the Company launched Genius High as a scalable model for AI-powered Future Schools, integrated with the Student AI and Teacher AI platforms, as part of Genius OS.

About Genius Group

Genius Group (NYSE: GNS) is a global education group delivering AI powered, education and acceleration solutions for the future of work. Genius Group serves 6 million users in over 100 countries through its Genius City model and online digital marketplace of AI training, AI tools and AI talent. It provides personalized, entrepreneurial AI pathways combining human talent with AI skills and AI solutions at the individual, enterprise and government level. To learn more, please visit geniusgroup.ai

Forward-Looking Statements 

Statements made in this press release include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements can be identified by the use of words such as “may,” “will”, “plan,” “should,” “expect,” “anticipate,” “estimate,” “continue,” or comparable terminology. Such forward-looking statements are inherently subject to certain risks, trends and uncertainties, many of which the Company cannot predict with accuracy and some of which the Company might not even anticipate and involve factors that may cause actual results to differ materially from those projected or suggested. Readers are cautioned not to place undue reliance on these forward-looking statements and are advised to consider the factors listed above together with the additional factors under the heading “Risk Factors” in the Company’s Annual Reports on Form 20-F, as may be supplemented or amended by the Company’s Reports of a Foreign Private Issuer on Form 6-K. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise. No information in this press release should be construed as any indication whatsoever of the Company’s future revenues, results of operations, or stock price.

Non-IFRS Financial Measure

We have included Adjusted EBITDA because it is a key measure used by our management and board of directors to understand and evaluate our core operating performance and trends, to prepare and approve our annual budget and to develop short- and long-term operational plans. In particular, the exclusion of certain expenses in calculating Adjusted EBITDA can provide a useful measure for period-to-period comparisons of our core business. We calculate Adjusted EBITDA as net profit / loss for the period plus income taxes and social contribution plus / minus finance revenue / expense result plus depreciation and amortization plus impairments plus revaluation adjustment of contingent liabilities plus share-based compensation expenses plus bad debt provision.

Contacts

For enquiries, contact investor@geniusgroup.ai